|
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism |
43.93 |
|
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis |
42.23 |
|
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] |
36.63 |
|
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. |
28.91 |
|
hnRNP C is a key regulator of protein synthesis in mitosis |
27.16 |
|
Region-specific Innate Antiviral Responses of the Human Epididymis |
26.16 |
|
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function |
25.4 |
|
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells |
25.31 |
|
DHX15 regulates CMTR1-dependent gene expression and cell proliferation |
22.41 |
|
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B |
22.3 |
|
Human cell line and subcutaneous tumor |
21.23 |
|
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 |
20.82 |
|
Sensing self and nonself circular RNAs |
20.17 |
|
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment |
19.54 |
|
RIG-I and MDA5 fRIP during KSHV lytic reactivation |
19.5 |
|
m6A-seq data analysis of control and PCIF1 knockdown transcriptome |
18.68 |
|
Role of XRN2 ribonucleolytic activity in RNA metabolism |
18.31 |
|
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells |
17.95 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) |
17.55 |
|
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] |
17.4 |
|
Altering cancer transcriptomes using epigenomic inhibitors |
17.4 |
|
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells |
17.37 |
|
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha |
17.01 |
|
ETV7 and interferon response |
17.01 |
|
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells |
16.91 |
|
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells |
16.72 |
|
HNRNPL and its RNA Targets in Prostate Cancer |
16.72 |
|
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality |
16.42 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 |
16.24 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] |
16.24 |
|
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO |
15.64 |
|
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines |
15.47 |
|
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA |
15.43 |
|
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription |
15.26 |
|
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] |
15.26 |
|
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] |
14.89 |
|
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] |
14.35 |
|
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion |
14.28 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) |
14.27 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator |
14.08 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] |
14.08 |
|
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging |
13.99 |
|
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells |
13.93 |
|
Mapping interactions for the TNIP2 hub protein |
13.77 |
|
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level |
13.72 |
|
Ribosomal footprinting of CN34-Parental and CN34-LM1a |
13.7 |
|
Determination of tRNA aminoacylation levels by high throughput sequencing |
13.52 |
|
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency |
13.29 |
|
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line |
13.17 |
|
Wnt addiction of genetically defined cancers reversed by PORCN inhibition |
13.03 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues |
12.84 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) |
12.84 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] |
12.8 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression |
12.8 |
|
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation |
12.77 |
|
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 |
12.64 |
|
Global expression profiles in cardiac progenitor cells generated by ISX-9 |
12.64 |
|
Ribosomal footprinting of MDA-Parental and MDA-LM2 |
12.55 |
|
Regulation of protein translation during mitosis |
12.46 |
|
Tracking of dCas9-methyltransferase footprints |
12.43 |
|
MYC dependent mRNA translation shapes gene expression and cell biology |
12.42 |
|
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. |
12.37 |
|
Gene expression changes after LOC550643 silencing |
12.29 |
|
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] |
12.11 |
|
HEXIM1 is induced by DHODH inhibition to suppress melanoma |
12.03 |
|
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] |
12.03 |
|
Single-nucleotide-resolution mapping of HBV promoters using CAGE |
11.85 |
|
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing |
11.58 |
|
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 |
11.16 |
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells |
11.14 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] |
11.14 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development |
11.14 |
|
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells |
11.09 |
|
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] |
11.01 |
|
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state |
10.96 |
|
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision |
10.95 |
|
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). |
10.9 |
|
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription |
10.82 |
|
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment |
10.71 |
|
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene |
10.71 |
|
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] |
10.7 |
|
Effect of mitochondria deficiency on senescence-associated gene expression |
10.63 |
|
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. |
10.57 |
|
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing |
10.49 |
|
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] |
10.49 |
|
RNAseq of HEK293 cells after Chtop knockdown |
10.41 |
|
Co-transcriptional loading of RNA export factors shapes the human transcriptome |
10.41 |
|
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] |
10.27 |
|
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
10.27 |
|
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells |
10.21 |
|
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease |
10.18 |
|
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) |
10.18 |
|
Profiling of escape kinetics of viruses subjected to RNAi |
10.18 |
|
Transcriptome analysis upon C6orf203 silencing |
10.12 |
|
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A |
10.12 |
|
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro |
10.04 |
|
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias |
10.04 |
|
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells |
9.91 |
|
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes |
9.91 |
|
Transcriptome analysis of Zika infected neural stem cells |
9.91 |
|
Zika infected neural stem cells |
9.91 |
|
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] |
9.87 |
|
3’ Uridylation Expands miRNA Target Repertoire |
9.86 |
|
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy |
9.8 |
|
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 |
9.72 |
|
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication |
9.66 |
|
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells |
9.62 |
|
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] |
9.6 |
|
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines |
9.6 |
|
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) |
9.49 |
|
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination |
9.49 |
|
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins |
9.37 |
|
Solid phase chemistry to covalently and reversibly capture thiolated RNA |
9.17 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock |
9.15 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] |
9.15 |
|
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines |
9.1 |
|
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes |
9.09 |
|
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing |
9.08 |
|
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA |
9.04 |
|
An RNA-centric dissection of host complexes controlling flavivirus infection |
9.03 |
|
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] |
9.03 |
|
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells |
9.0 |
|
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects |
9.0 |
|
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway |
8.95 |
|
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters |
8.93 |
|
MOF acetyl transferase regulates transcription and respiration in mitochondria |
8.93 |
|
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression |
8.86 |
|
RNA transcriptome analysis during HSV-1 infection |
8.84 |
|
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line |
8.84 |
|
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 |
8.84 |
|
Lipid degradation promotes prostate cancer cell survival |
8.82 |
|
RNA polymerase in pre-B-ALL cell lines |
8.82 |
|
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells |
8.78 |
|
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] |
8.78 |
|
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate |
8.73 |
|
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state |
8.67 |
|
A prostate cancer chromatin interaction map |
8.66 |
|
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation |
8.62 |
|
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia |
8.62 |
|
CROP-Seq in Primary Human T Cells |
8.6 |
|
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis |
8.5 |
|
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression |
8.48 |
|
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] |
8.41 |
|
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer |
8.41 |
|
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] |
8.41 |
|
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 |
8.41 |
|
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells |
8.36 |
|
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium |
8.34 |
|
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) |
8.33 |
|
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer |
8.29 |
|
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells |
8.29 |
|
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains |
8.27 |
|
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer |
8.26 |
|
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] |
8.15 |
|
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 |
8.15 |
|
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma |
8.13 |
|
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] |
8.13 |
|
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. |
8.07 |
|
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] |
8.07 |
|
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF |
8.07 |
|
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient |
8.06 |
|
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis |
8.05 |
|
Global analysis of alternative splicing regulated by RBM10 |
8.04 |
|
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ |
7.98 |
|
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells |
7.97 |
|
CD73 knockdown effect in pancreatic cancer cell lines |
7.94 |
|
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation |
7.89 |
|
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes |
7.84 |
|
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] |
7.84 |
|
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] |
7.82 |
|
Convergent roles of ATF3 and CSL in chromatin control of CAF activation |
7.82 |
|
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression |
7.82 |
|
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues |
7.79 |
|
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells |
7.78 |
|
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] |
7.78 |
|
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs |
7.76 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
7.75 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
7.75 |
|
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy |
7.73 |
|
Human cells contain natural double-stranded RNAs with potential regulatory capacity |
7.66 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function |
7.64 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] |
7.64 |
|
TGF-β regulation of miRNA expression in pancreatic cancer |
7.63 |
|
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs |
7.59 |
|
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development |
7.59 |
|
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches |
7.55 |
|
H1609088 Human RNA-Sequencing |
7.54 |
|
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization |
7.52 |
|
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells |
7.52 |
|
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors |
7.51 |
|
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression |
7.49 |
|
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] |
7.49 |
|
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] |
7.49 |
|
Human neutrophil genome during PMA- and E. coli encounter-induced activation |
7.47 |
|
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation |
7.47 |
|
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations |
7.46 |
|
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] |
7.46 |
|
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma |
7.43 |
|
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] |
7.42 |
|
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins |
7.41 |
|
Patient-derived luminal breast cancer xenografts with progestins |
7.41 |
|
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation |
7.4 |
|
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia |
7.35 |
|
mRNA expression profile of Lymphocytes |
7.34 |
|
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells |
7.32 |
|
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination |
7.29 |
|
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. |
7.21 |
|
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. |
7.21 |
|
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct |
7.12 |
|
Transcriptome profiling of Normal and Cancerous Prostate Cells |
7.12 |
|
The landscape of alternative splicing in aggressive prostate cancers |
7.06 |
|
RNA-seq of RKO cells with cTAZ KO or putback |
7.02 |
|
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] |
7.0 |
|
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice |
7.0 |
|
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype |
6.99 |
|
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells |
6.92 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer |
6.9 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] |
6.9 |
|
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II |
6.89 |
|
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. |
6.89 |
|
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure |
6.87 |
|
RNA m5C Methylation in breast cancer using MeRIP-Seq |
6.85 |
|
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 |
6.84 |
|
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC |
6.81 |
|
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth |
6.71 |
|
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] |
6.7 |
|
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer |
6.7 |
|
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis |
6.69 |
|
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] |
6.69 |
|
RNA-seq in SUNE-1 cells after downregulation of DANCR expression |
6.67 |
|
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies |
6.63 |
|
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) |
6.61 |
|
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states |
6.61 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line |
6.55 |
|
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element |
6.55 |
|
Transcriptional profiling of LS1034 cells treated with tepoxalin |
6.52 |
|
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] |
6.41 |
|
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] |
6.41 |
|
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma |
6.41 |
|
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 |
6.38 |
|
MYCL and EP400 are required for Max and MCPyV mediated gene activation |
6.38 |
|
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. |
6.29 |
|
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC |
6.28 |
|
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation |
6.26 |
|
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation |
6.26 |
|
Gene expression profile of LMSU gastric cancer cell p53 KO and KD |
6.22 |
|
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells |
6.21 |
|
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells |
6.17 |
|
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] |
6.12 |
|
Effect of ILF3 on translation during homeostasis and the antiviral response |
6.11 |
|
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] |
6.08 |
|
Global analysis of enhancer targets: Mosaic-seq |
6.07 |
|
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling |
6.06 |
|
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository |
6.06 |
|
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate |
5.99 |
|
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. |
5.99 |
|
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer |
5.95 |
|
IDH3a KO RNA-seq |
5.94 |
|
The age and genomic integrity of neurons after cortical stroke in humans |
5.93 |
|
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component |
5.93 |
|
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells |
5.89 |
|
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients |
5.84 |
|
The Genetic Landscape of Diamond-Blackfan Anemia |
5.83 |
|
Comparative Analysis of Cas9 Activators Across Multiple Species |
5.78 |
|
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons |
5.7 |
|
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
5.66 |
|
Capturing the Interactome of Newly Transcribed RNA (RICK) |
5.64 |
|
Capturing the Interactome of Newly Transcribed RNA |
5.64 |
|
Trans-differentiation of human adult peripheral blood T cells into neurons |
5.63 |
|
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium |
5.58 |
|
EWSR1 influences alternative splicing through direct and indirect mechanisms |
5.58 |
|
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition |
5.51 |
|
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins |
5.5 |
|
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 |
5.49 |
|
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] |
5.49 |
|
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 |
5.48 |
|
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors |
5.47 |
|
SLIGRL-induced gene expression changes in NHEK cells |
5.43 |
|
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome |
5.36 |
|
Triple vectors expand AAV transfer capacity in the retina |
5.32 |
|
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes |
5.25 |
|
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell |
5.23 |
|
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats |
5.22 |
|
ARS2 is a general suppressor of pervasive transcription [RNAseq] |
5.19 |
|
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease |
5.18 |
|
RNA-seq of IL-4 stimulated human keratinocytes |
5.16 |
|
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 |
5.15 |
|
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition |
5.14 |
|
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] |
5.14 |
|
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome |
5.14 |
|
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex |
5.14 |
|
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] |
5.13 |
|
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells |
5.08 |
|
STX4 Over-Expression in Human islets |
5.07 |
|
Gene expression profiling of leukemia cells following asparagine depletion |
5.07 |
|
Human HAP1 cells before and after nutrient deprivation |
5.05 |
|
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation |
5.05 |
|
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist |
4.97 |
|
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation |
4.93 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) |
4.93 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability |
4.93 |
|
RNA sequencing of primary human platelets and in vitro cell lines |
4.93 |
|
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 |
4.92 |
|
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] |
4.88 |
|
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) |
4.78 |
|
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] |
4.69 |
|
Co-regulation of splicing by Rbfox1 and hnRNP M |
4.69 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
4.67 |
|
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq |
4.6 |
|
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts |
4.6 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes |
4.56 |
|
Targeting EZH2 in MYCN-amplified Neuroblastoma |
4.56 |
|
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] |
4.56 |
|
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs |
4.54 |
|
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease |
4.53 |
|
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients |
4.53 |
|
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients |
4.53 |
|
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons |
4.46 |
|
Molecular Criteria for Defining the Naive Human Pluripotent State |
4.43 |
|
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome |
4.43 |
|
O-glcnAc reprograms cellular energetics |
4.39 |
|
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors |
4.36 |
|
RNA expression analysis upon JMJD1C depletion |
4.36 |
|
RNA sequencing of mechanically strained NHEKs and control NHEKs |
4.34 |
|
TOP2B disturbed the quality of human oocytes with advanced maternal age |
4.32 |
|
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression |
4.3 |
|
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] |
4.3 |
|
Transcriptome of diurnal human blood neutrophils |
4.29 |
|
K562 polyA RNA-Seq |
4.23 |
|
RNA sequencing of human mammary epithelial cells |
4.22 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
4.21 |
|
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells |
4.2 |
|
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing |
4.2 |
|
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood |
4.18 |
|
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals |
4.17 |
|
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) |
4.16 |
|
Enhancer activation during EGF response |
4.11 |
|
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine |
4.09 |
|
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells |
4.05 |
|
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 |
3.91 |
|
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] |
3.85 |
|
4sUDRB-seq: measuring transcription elongation and initiation genomewide |
3.83 |
|
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo |
3.83 |
|
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF |
3.65 |
|
Effect of BB608 on Gene Expression in HNSCC Cell Line |
3.63 |
|
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome |
3.46 |
|
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. |
3.42 |
|
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions |
3.42 |
|
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
3.34 |
|
Gene expression profile in breast cancer cells |
3.34 |
|
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 |
3.3 |
|
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] |
3.3 |
|
ADAR1-editing of cellular and measles virus-derived duplex RNA |
3.25 |
|
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes |
3.25 |
|
RNA-Seq of PRMT1 overexpression ECA109 cells |
3.25 |
|
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells |
3.22 |
|
In vitro modeling of human germ cell development using pluripotent stem cells |
3.19 |
|
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq |
3.13 |
|
Role of COP1 on MAP kinase transcriptional output in melanoma |
3.13 |
|
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma |
3.07 |
|
Interaction between mitoNEET and NAF-1 in cancer cells |
3.04 |
|
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] |
2.99 |
|
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) |
2.99 |
|
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics |
2.97 |
|
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain |
2.95 |
|
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation |
2.9 |
|
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs |
2.88 |
|
Effect of PRDM11 depletion in U2932 cells |
2.88 |
|
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. |
2.86 |
|
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] |
2.79 |
|
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans |
2.79 |
|
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. |
2.78 |
|
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells |
2.72 |
|
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 |
2.69 |
|
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown |
2.67 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
2.67 |
|
Transcriptome landscape of HeLa response upon triamcinolone acetonide |
2.6 |
|
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function |
2.58 |
|
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. |
2.56 |
|
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP |
2.55 |
|
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia |
2.49 |
|
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. |
2.45 |
|
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha |
2.45 |
|
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells |
2.44 |
|
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression |
2.44 |
|
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models |
2.43 |
|
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy |
2.37 |
|
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture |
2.36 |
|
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation |
2.36 |
|
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene |
2.29 |
|
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 |
2.27 |
|
DRB/GRO-Seq -/+ UV |
2.24 |
|
The contribution of Alu exons to the human proteome |
2.19 |
|
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO |
2.15 |
|
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage |
2.15 |
|
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways |
2.11 |
|
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples |
2.11 |
|
MicroRNA-125a-5p overexpression in human macrophages |
2.06 |
|
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid |
2.06 |
|
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. |
2.01 |
|
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia |
1.97 |
|
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) |
1.95 |
|
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors |
1.95 |
|
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] |
1.95 |
|
Myc activation coordinates gene transcription and protein translation responses |
1.92 |
|
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] |
1.9 |
|
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance |
1.79 |
|
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells |
1.78 |
|
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] |
1.76 |
|
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity |
1.76 |
|
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer |
1.75 |
|
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells |
1.68 |
|
High-resolution comparative analysis of great ape genomes |
1.62 |
|
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. |
1.58 |
|
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus |
1.53 |
|
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] |
1.52 |
|
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming |
1.52 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) |
1.44 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling |
1.44 |
|
single cell RNA-seq from Purkinje cell (ENCSR888LYA) |
1.42 |
|
HBEC-shp53-PCHD7 |
1.41 |
|
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
1.39 |
|
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] |
1.36 |
|
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] |
1.36 |
|
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine |
1.33 |
|
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique |
1.27 |
|
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia |
1.25 |
|
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] |
1.22 |
|
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants |
1.19 |
|
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells |
1.19 |
|
Transcriptomic analysis of LSD1 |
1.17 |
|
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO |
1.13 |
|
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells |
1.13 |
|
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells |
1.13 |
|
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration |
1.09 |
|
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness |
1.08 |
|
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm |
1.06 |
|
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) |
1.0 |
|
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression |
0.95 |
|
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients |
0.95 |
|
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program |
0.94 |
|
Widespread regulated alternative splicing of single codons accelerates proteome evolution |
0.94 |
|
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma |
0.93 |
|
SF3B1 Degron knockdown RNA-seq |
0.91 |
|
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis |
0.89 |
|
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] |
0.89 |
|
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation |
0.87 |
|
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein |
0.84 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] |
0.84 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. |
0.84 |
|
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing |
0.83 |
|
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq |
0.83 |
|
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA |
0.81 |
|
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence |
0.72 |
|
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells |
0.71 |
|
Modulation of nonsense-mediated decay by rapamycin |
0.68 |
|
WNT signaling memory is required for ACTIVIN to function as a morphogen |
0.67 |
|
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors |
0.66 |
|
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles |
0.62 |
|
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 |
0.59 |
|
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood |
0.56 |
|
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] |
0.51 |
|
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] |
0.51 |
|
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer |
0.51 |
|
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) |
0.5 |
|
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex |
0.5 |
|
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells |
0.48 |
|
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation |
0.47 |
|
Expression profiling of MCF-7 cells with treatment of TCDD |
0.46 |
|
Expression profiling of MCF-7 cells with 10nM treatment of TCDD |
0.46 |
|
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors |
0.46 |
|
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. |
0.45 |
|
Regulation of hypoxia-inducible factor activity by ZMYND8 |
0.44 |
|
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells |
0.42 |
|
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK |
0.42 |
|
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] |
0.4 |
|
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins |
0.38 |
|
A single-cell transcriptome atlas of the human pancreas |
0.37 |
|
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) |
0.34 |
|
Expression profile of MM.1S tumors folloiwing treatment with bortezomib |
0.28 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] |
0.28 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 |
0.28 |
|
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line |
0.26 |
|
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons |
0.25 |
|
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT |
0.24 |
|
iPSC derived motor neuron cultures from C9ORF72 carriers |
0.22 |
|
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects |
0.2 |
|
circRNA-sequencing |
0.16 |
|
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) |
0.14 |
|
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling |
0.14 |
|
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors |
0.13 |
|
Human Tfh cell RNA bulk sequencing |
0.11 |
|
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons |
0.11 |
|
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq |
0.07 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) |
0.05 |
|
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer |
0.03 |
|
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] |
0.03 |
|
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly |
0.01 |
|
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) |
0.0 |
|
Interphase condensins regulate ligand-depedent enhancer activation |
0.0 |